{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T04:18:51Z","timestamp":1759033131865},"reference-count":46,"publisher":"Informa UK Limited","issue":"6","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Current Medical Research and Opinion"],"published-print":{"date-parts":[[2017,6,3]]},"DOI":"10.1080\/03007995.2017.1299701","type":"journal-article","created":{"date-parts":[[2017,2,23]],"date-time":"2017-02-23T12:18:22Z","timestamp":1487852302000},"page":"1057-1066","update-policy":"http:\/\/dx.doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":4,"title":["The impact of antidepressant treatments on family functioning in adults with major depressive disorder: a post hoc comparison of vortioxetine and agomelatine"],"prefix":"10.1080","volume":"33","author":[{"given":"Cl\u00e9ment","family":"Fran\u00e7ois","sequence":"first","affiliation":[{"name":"Lundbeck LLC, Deerfield, IL, United States;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca","family":"Nielsen","sequence":"additional","affiliation":[{"name":"H Lundbeck A\/S, Valby, Denmark;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalya","family":"Danchenko","sequence":"additional","affiliation":[{"name":"Lundbeck SAS, Issy Les Moulineaux, France;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valerie","family":"Williams","sequence":"additional","affiliation":[{"name":"RTI Health Solutions, Research Triangle Park, NC, United States;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christophe","family":"Lan\u00e7on","sequence":"additional","affiliation":[{"name":"Hospital Ste Marguerite, CHU Marseille, France"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2017,3,28]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2015.18392"},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.1080\/0954026031000136866"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.1111\/j.1752-0606.1983.tb01497.x"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.126.2.164"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.147.9.1128"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.1111\/j.1545-5300.1994.00053.x"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291707002073"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.2006.163.6.1001"},{"key":"CIT0009","unstructured":"Food and Drug Administration. Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims, 2009. Available at: http:\/\/www.fda.gov\/downloads\/Drugs\/GuidanceComplianceRegulatoryInformation\/Guidances\/UCM193282.pdf [Last accessed 27 July 2016]"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.1185\/03007995.2012.658910"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1185\/03007995.2015.1135111"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1002\/hup.2424"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.1021\/jm101459g"},{"issue":"1","key":"CIT0014","first-page":"47","volume":"16","author":"Westrich L","year":"2012","journal-title":"Int J Psychiatry Clin Pract"},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.1017\/S1461145711001027"},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2011.11.008"},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.1177\/0269881112441866"},{"key":"CIT0018","first-page":"138","volume":"29","author":"Boulenger J-P","year":"2014","journal-title":"in the acute treatment of adult patients with major depressive disorder. Int Clin Psychopharmacol"},{"key":"CIT0019","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.11m07470"},{"key":"CIT0020","unstructured":"Jacobsen PL, Mahableshwarkar AR, Serenko M, et\u00a0al. A randomized, double-blind, placebo-controlled study of the efficacy and safety of vortioxetine 10\u2009mg and 20\u2009mg in adults with major depressive disorder. Poster NR9-06 presented at the 166th Annual Meeting of the APA, San Francisco, CA, USA, 2013"},{"key":"CIT0021","doi-asserted-by":"publisher","DOI":"10.1097\/YIC.0b013e3283542457"},{"key":"CIT0022","unstructured":"Mahableshwarkar A, Jacobsen PL, Serenko M, et\u00a0al. A duloxetine-referenced fixed dose study comparing efficacy and safety of 2 vortioxetine doses in the acute treatment of adult patients with MDD. Poster NR9-01 presented at the 166th Annual Meeting of the APA, San Francisco, CA, USA, 2013"},{"key":"CIT0023","doi-asserted-by":"publisher","DOI":"10.1185\/03007995.2012.761600"},{"key":"CIT0024","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.bp.112.120196"},{"key":"CIT0025","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g1888"},{"key":"CIT0026","volume-title":"The Maudsley Prescribing Guidelines in Psychiatry","author":"Taylor D","year":"2012"},{"key":"CIT0027","doi-asserted-by":"publisher","DOI":"10.1176\/appi.books.9780890423349"},{"key":"CIT0028","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.134.4.382"},{"key":"CIT0029","unstructured":"International Conference on Harmonisation. Guideline for good clinical practice, 1996. Available at: http:\/\/www.ich.org\/fileadmin\/Public_Web_Site\/ICH_Products\/Guidelines\/Efficacy\/E6\/E6_R1_Guideline.pdf [Last accessed 27 July 2016]"},{"key":"CIT0030","unstructured":"World Medical Association. Declaration of Helsinki, 2008. Available at: http:\/\/www.wma.net\/en\/30publications\/10policies\/b3\/17c.pdf [Last accessed 27 July 2016]"},{"key":"CIT0031","volume-title":"The anxiety disease","author":"Sheehan DV.","year":"1983"},{"key":"CIT0032","doi-asserted-by":"publisher","DOI":"10.1097\/00004850-199606003-00015"},{"key":"CIT0033","first-page":"99","volume":"16","author":"EuroQol Group.","year":"1990","journal-title":"Health Policy"},{"key":"CIT0034","volume-title":"The EuroQol instrument: an index of health-related quality of life","author":"Kind P.","year":"1996","edition":"2"},{"key":"CIT0035","doi-asserted-by":"crossref","unstructured":"Guy W. ECDEU assessment manual for psychopharmacology (United States Department of Health, Education, and Welfare Publication No. 76-338). Rockville, MD: National Institute of Mental Health, 1976:218-22","DOI":"10.1037\/e591322011-001"},{"key":"CIT0036","volume-title":"Measuring health \u2013 a guide to rating scales and questionnaires","author":"McDowell I","year":"1996","edition":"2"},{"key":"CIT0037","doi-asserted-by":"publisher","DOI":"10.1111\/j.2044-8341.1959.tb00467.x"},{"key":"CIT0038","doi-asserted-by":"publisher","DOI":"10.1016\/0165-0327(88)90072-9"},{"key":"CIT0039","volume-title":"Committee for Medicinal Products for Human Use, Reflection paper on the regulatory guidance for the use of health-related quality of life (HRQL) measures in the evaluation of Medicinal products","author":"European Medicines Agency (EMA).","year":"2005"},{"key":"CIT0040","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1961.01710120031004"},{"key":"CIT0041","first-page":"588","volume":"67","author":"Beck AT","year":"1996","journal-title":"J Personality"},{"key":"CIT0042","doi-asserted-by":"publisher","DOI":"10.1177\/014662167700100306"},{"key":"CIT0043","doi-asserted-by":"publisher","DOI":"10.1177\/089826439300500202"},{"key":"CIT0044","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.23.1.56"},{"key":"CIT0045","doi-asserted-by":"publisher","DOI":"10.1097\/NMD.0b013e31811f400f"},{"key":"CIT0046","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.59.3.233"}],"container-title":["Current Medical Research and Opinion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/03007995.2017.1299701","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,6]],"date-time":"2020-09-06T14:51:30Z","timestamp":1599403890000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/03007995.2017.1299701"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,28]]},"references-count":46,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,6,3]]}},"alternative-id":["10.1080\/03007995.2017.1299701"],"URL":"https:\/\/doi.org\/10.1080\/03007995.2017.1299701","relation":{},"ISSN":["0300-7995","1473-4877"],"issn-type":[{"value":"0300-7995","type":"print"},{"value":"1473-4877","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,28]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=icmo20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=icmo20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2016-08-29","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-02-20","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-03-28","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}